For the 2025, Ballard delivered revenue of $32,500,000 an increase of 120% year over year driven primarily by the bus and rail deliveries. Gross margin improved to 15%, compared to negative 56% in Q3 twenty twenty four. A 71 improvement. This reflects lower manufacturing overhead, continued product cost reduction, and a net reduction in owner's contract provisions. This reduction in owner's contract provisions coupled with a higher margin one time off road sales transaction contributed to the outsized gross margin performance in the quarter. Without these one time benefits, our gross margin would be slightly negative, still illustrating a marked year on year and quarter on quarter improvement. As Marty highlighted, we continue to make measured progress towards gross margin expansion and expect this to be reflected in our 2026 outlook. Total operating expenses were 34,900,000.0 down 36% year over year or 55% lower when excluding restructuring costs. Cash operating costs declined 40% year over year as the benefits of restructuring actions flowed through to our results. The rightsizing of our corporate cost structure, while never easy, was critical for our long term sustainability and financial health. Adjusted EBITDA improved to negative 31,200,000.0 compared to negative $60,100,000 in the prior year. Cash used by operating activities was 22,900,000.0 an improvement from $28,600,000 in 2024. We ended the quarter with 5 and $25,700,000 in cash and cash equivalents no bank debt, no near term financing requirements. Our strong balance sheet and firm hand on prudent capital allocation is a amongst peers key differentiator and provides us with business flexibility and resilience in this dynamic macro environment. Looking ahead, consistent with prior practice, are not providing specific revenue net income or margin guidance given the early stage of market development. We continue to expect revenue to be back half weighted for the year and total operating expenses excluding restructuring charges are expected to be below the low end of our 100,000,000 to $120,000,000 guidance range. Including restructuring costs expenses are expected to be towards the high end of the guidance range. We now expect capital expenditures of 8 to $12,000,000 down from our prior guidance of 15,000,000 to 25,000,000 reflecting disciplined capital allocation and deferred facility investments.